Literature DB >> 22264862

Lymphogranuloma venereum: a hidden emerging problem, Barcelona, 2011.

H Vargas-Leguas1, P Garcia de Olalla, M Arando, P Armengol, Mj Barbera, M Vall, A Vives, G Martin-Ezquerra, M Alsina, J Blanco, C Munoz, E Caballero, A Andreu, M Ros, P Gorrindo, A Dominguez, Ja Cayla.   

Abstract

From the beginning of 2007 until the end of 2011, 146 cases of lymphogranuloma venereum (LGV) were notified to the Barcelona Public Health Agency. Some 49% of them were diagnosed and reported in 2011, mainly in men who have sex with men. Almost half of them, 32 cases, were reported between July and September. This cluster represents the largest since 2004. This article presents the ongoing outbreak of LGV in Barcelona.

Entities:  

Mesh:

Year:  2012        PMID: 22264862

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  10 in total

1.  Characterization of Chlamydia trachomatis plasmid-encoded open reading frames.

Authors:  Siqi Gong; Zhangsheng Yang; Lei Lei; Li Shen; Guangming Zhong
Journal:  J Bacteriol       Date:  2013-06-21       Impact factor: 3.490

2.  Minimum spread of the new Swedish variant of Chlamydia trachomatis and distribution of C. trachomatis ompA genotypes in three geographically distant areas of Spain, 2011-2012.

Authors:  L Piñeiro; S Bernal; A Bordes; J C Palomares; R Gilarranz; M A von Wichmann; G Cilla
Journal:  Infection       Date:  2014-07-24       Impact factor: 3.553

3.  Genotyping Chlamydia trachomatis strains among men who have sex with men from a Northern Spain region: a cohort study.

Authors:  P Mejuto; J A Boga; M Junquera; A Torreblanca; P S Leiva
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

4.  Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study.

Authors:  Marc Martí-Pastor; Patricia García de Olalla; Maria-Jesús Barberá; Christian Manzardo; Inma Ocaña; Hernando Knobel; Mercè Gurguí; Victoria Humet; Martí Vall; Esteban Ribera; Judit Villar; Gemma Martín; Maria A Sambeat; Andres Marco; Alvaro Vives; Mercè Alsina; Josep M Miró; Joan A Caylà
Journal:  BMC Public Health       Date:  2015-10-05       Impact factor: 3.295

5.  Clinical predictors of rectal lymphogranuloma venereum infection: results from a multicentre case-control study in the U.K.

Authors:  S N S Pallawela; A K Sullivan; N Macdonald; P French; J White; G Dean; A Smith; A J Winter; S Mandalia; S Alexander; C Ison; H Ward
Journal:  Sex Transm Infect       Date:  2014-03-31       Impact factor: 3.519

Review 6.  Lymphogranuloma venereum: diagnostic and treatment challenges.

Authors:  Romana Ceovic; Sandra Jerkovic Gulin
Journal:  Infect Drug Resist       Date:  2015-03-27       Impact factor: 4.003

7.  Low Prevalence of Urethral Lymphogranuloma Venereum Infections Among Men Who Have Sex With Men: A Prospective Observational Study, Sexually Transmitted Infection Clinic in Amsterdam, the Netherlands.

Authors:  Nynke H N de Vrieze; Bart Versteeg; Sylvia M Bruisten; Martijn S van Rooijen; Jannie J van der Helm; Henry J C de Vries
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

8.  Lymphogranuloma venereum in Barcelona, 2007-2012: the role of seroadaptation in men who have sex with men.

Authors:  J M Reyes-Urueña; P Garcia De Olalla; M Vall-Mayans; M Arando; E Caballero; J A Cayla
Journal:  Epidemiol Infect       Date:  2014-03-18       Impact factor: 4.434

9.  Transformation of sexually transmitted infection-causing serovars of chlamydia trachomatis using Blasticidin for selection.

Authors:  Honglei Ding; Siqi Gong; Yingxin Tian; Zhangsheng Yang; Robert Brunham; Guangming Zhong
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

Review 10.  Project YOURLIFE (What Young People Think and Feel about Relationships, Love, Sexuality, and Related Risk Behavior): Cross-sectional and Longitudinal Protocol.

Authors:  Silvia Carlos; Alfonso Osorio; María Calatrava; Cristina Lopez-Del Burgo; Miguel Ruiz-Canela; Jokin de Irala
Journal:  Front Public Health       Date:  2016-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.